Soleno Therapeutics to Report Third Quarter 2025 Financial Results on November 4, 2025, at 4:30 PM ET

Core Points - Soleno Therapeutics, Inc. will report its third quarter 2025 financial results and operational highlights on November 4, 2025, after U.S. market close [1] - A conference call and webcast will be held at 4:30 PM Eastern Time to discuss the results and provide business updates [1][2] Company Overview - Soleno Therapeutics focuses on developing and commercializing novel therapeutics for rare diseases [3] - The company's first commercial product is VYKAT XR (diazoxide choline) extended-release tablets, designed for treating hyperphagia in individuals with Prader-Willi syndrome aged 4 years and older [3]